The National Academies
Health and Medicine Division
Explore by Topic
Biomedical and Health Research
Children, Youth and Families
Food and Nutrition
Health Care Workforce
Health Services, Coverage, and Access
Military and Veterans Health
Quality and Patient Safety
Select Populations and Health Equity
Substance Use and Mental Health
Displaying: 21 to 30 of 44 Meetings
Facing the Reality of Multidrug-Resistant Tuberculosis: Challenges and Potential Solutions in India
Date: April 18, 2011 - April 21, 2011 (9:00 AM Eastern)
Burden and profile of drug-resistant tuberculosis in India and globally; Preventing transmission of drug-resistant tuberculosis / infection control strategies
Advancing Regulatory Science for Medical Countermeasure Development - A Workshop
Date: March 29, 2011 - March 30, 2011 (8:00 AM Eastern)
In response to a request from the Food and Drug Administration (FDA), the Institute of Medicine will conduct a workshop that will explore issues related to Advancing Regulatory Science for Medical Countermeasure Development.
The New Profile of Drug Resistant Tuberculosis:A Global and Local Perspective - Moscow, Russia
Date: May 26, 2010 - May 27, 2010 (9:00 AM Eastern)
Sponsored by the U.S. National Academy of Sciences, IOM, Forum on Drug Discovery, Development, and Translation and the Russian Academy of Medical Sciences, this 2-day workshop addressed the spread of multidrug-resistant (MDR) tuberculosis in Russia and across the globe, as well as the rapid emergence and spread of extensively drug resistant (XDR) tuberculosis.
International Workshop on the Growing Threat of Drug-Resistant Tuberculosis: South Africa
Date: March 3, 2010 - March 4, 2010 (12:00 AM Eastern)
Building a National Framework for the Establishment of Regulatory Science for Drug Development
Date: February 26, 2010 (8:00 AM Eastern)
With the advent of emerging technologies and a national focus on drug safety, the need for sound science to make good regulatory decisions is more urgent than ever. The IOM Drug Forum will hold a public workshop to examine the state of the science of drug regulation.
The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from Discovery Through Approval
Date: February 23, 2010 - February 24, 2010 (8:00 AM Eastern)
Transforming Clinical Research in the U.S.
Date: October 7, 2009 - October 8, 2009 (12:00 AM Eastern)
Through a series of case studies and expert perspectives, participants will examine clinical research networks and large, phase III trials in different disease areas—cardiovascular diseases, depression, cancer, and diabetes.
Community Update: Improving The Science Of Drug Safety
Date: September 2, 2009 - October 2, 2009 (10:30 AM Eastern)
Biomedical Science & Policy Discussion Series
Summer 2009 Public Symposium
Date: July 10, 2009 (8:30 AM Eastern)
Public Workshop on Streamlining Clinical Trial and Material Transfer Negotiations
Date: April 27, 2009 (1:30 PM Eastern)